Research and Markets: Global Visceral Pain Pipeline Review, H2 2015 - 12 Companies & 19 Drug Profiles
November 27 2015 - 06:51AM
Business Wire
Research and Markets
(http://www.researchandmarkets.com/research/h2zfrx/visceral_pain)
has announced the addition of the "Visceral Pain - Pipeline Review,
H2 2015" report to their offering.
This report provides comprehensive information on the
therapeutic development for Visceral Pain, complete with
comparative analysis at various stages, therapeutics assessment by
drug target, mechanism of action (MoA), route of administration
(RoA) and molecule type, along with latest updates, and featured
news and press releases. It also reviews key players involved in
the therapeutic development for Visceral Pain and special features
on late-stage and discontinued projects.
The report enhances decision making capabilities and help to
create effective counter strategies to gain competitive advantage.
It strengthens R&D pipelines by identifying new targets and
MOAs to produce first-in-class and best-in-class products.
Companies Involved in Therapeutics Development
- Addex Therapeutics Ltd
- Amorepacific Corporation
- Aros Pharma ApS
- Astellas Pharma Inc.
- Echo Pharmaceuticals B.V.
- GIcare Pharma Inc
- Grunenthal GmbH
- Hydra Biosciences, Inc.
- Nektar Therapeutics
- Neurim Pharmaceuticals Ltd
- Proteus SA
- RDD Pharma Ltd.
Drug Profiles
- ADX-71441
- ASP-7663
- dronabinol
- GIC-1001
- GIC-1002
- HC-030031
- neosaxitoxin
- NeuP-12
- nifedipine
- NKTR-195
- PAC-14028
- piromelatine
- PPC-5650
- PR-38
- RO-656570
- Small Molecule to Block Nav1.9 Channel for Pain
- Small Molecules to Antagonize TRPM8 for Overactive Bladder and
Pain
- Synthetic Peptides to Activate OXTR for Oncology and Abdominal
Pain
- URB-937
For more information visit
http://www.researchandmarkets.com/research/h2zfrx/visceral_pain
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151127005142/en/
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Sector: Central Nervous System